BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 January 2021 - 10:00PM
MAINZ, GERMANY, January 5, 2021 (GLOBE
NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the
Company”) announced today that CEO and Co-founder Ugur Sahin, M.D.,
will present a corporate overview and update at the virtual 39th
Annual J.P. Morgan Healthcare Conference on Monday, January 11,
2021, at 10.50am ET.
A live webcast of the presentation will be
available via the “Events & Presentations” page in the Investor
Relations section on the Company’s website at https://biontech.de/.
The replay of the webcast will be archived on the Company’s website
for 30 days following the conference.
About BioNTech
Biopharmaceutical New Technologies is a next generation
immunotherapy company pioneering novel therapies for cancer and
other serious diseases. The Company exploits a wide array of
computational discovery and therapeutic drug platforms for the
rapid development of novel biopharmaceuticals. Its broad portfolio
of oncology product candidates includes individualized and
off-the-shelf mRNA-based therapies, innovative chimeric antigen
receptor T cells, bi-specific checkpoint immuno-modulators,
targeted cancer antibodies and small molecules. Based on its deep
expertise in mRNA vaccine development and in-house manufacturing
capabilities, BioNTech and its collaborators are developing
multiple mRNA vaccine candidates for a range of infectious diseases
alongside its diverse oncology pipeline. BioNTech has established a
broad set of relationships with multiple global pharmaceutical
collaborators, including Genmab, Sanofi, Bayer Animal Health,
Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun
Pharma, and Pfizer. For more information, please visit
www.BioNTech.de.
BioNTech Contacts:
Media RelationsJasmina
Alatovic+49 89 62 81 75 46 Media@biontech.de
Investor RelationsSylke Maas,
Ph.D.+49 (0)6131 9084 1074Investors@biontech.de
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Apr 2023 to Apr 2024